StreetAlpha.app
Home › Stocks › BWAY

Brainsway Ltd. (BWAY)

$8.48
▼ −2.86%
LAST CLOSE · NOV 20

BrainsWay makes Deep TMS magnetic brain stimulation systems used to treat mental health disorders. It last closed at $8.48 on Nov 20, down 2.86% on the day.

AI Auto Pilots
Is BWAY in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BWAY.

Key Stats

Last 12 months
Results
Revenue
$46.1M
Net income
$5.3M
11.6% margin
Gross margin
74.5%
$34.3M gross profit
Operating margin
4.0%
$1.9M operating income
Balance sheet
Cash & equivalents
$67.9M
At Jun 30
Shareholder equity
$68.1M
ExchangeNasdaq
Financials history
FY2020: $22.1M$22.1MFY2020FY2021: $29.7M$29.7MFY2021FY2022: $27.2M$27.2MFY2022FY2023: $31.8M$31.8MFY2023FY2024: $41.0M$41.0MFY2024

From BWAY's SEC filings, latest 20-F for the period ending Jun 30, 2025 (filed Apr 20). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on file yet
Reported EPS
—
Quarter ended Dec 2020
Year ago EPS
—
Same quarter last year
Revenue
$7.1M
+12.3% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Not enough quarters on file yet.
Revenue by quarter
Dec 2019: $6.3MDec '19Dec 2020: $7.1MDec '20Latest $7.1M
StreetAlpha's call on BWAYStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on BWAY
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on BWAY

Technical Analysis

BWAY · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 25% below its 20 day and 38% below its 50 day average. It is 63% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 28), oversold. The nearest support is the Pivot S1 at $8.30, and the nearest resistance the Pivot at $8.63.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 7.8%/day
Key levels
$17.4052 week high+105.2%
$13.81200 day average+62.9%
$13.42100 day average+58.3%
$12.05Swing high (Oct 29)+42.1%
$11.7450 day average+38.4%
$10.5720 day average+24.6%
$8.81Pivot R1+3.9%
$8.63Pivot+1.8%
$8.48Last close
$8.30Pivot S1−2.1%
$7.1352 week low−15.9%
Indicators
RSI (14)27.90Oversold below 30Oversold
MACD-0.85Below its signal lineBearish
Stochastic2.3Near the bottom of its rangeOversold
ADX (14)25.0Trending down
Williams %R-99.2Oversold below −80, overbought above −20Oversold
CCI (20)-154.8Oversold below −100, overbought above 100Oversold
Rate of change−23.9%Change over 10 sessionsBearish
ATR (14)$0.66Typical daily range, 7.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for BWAY

What happened before

See how BWAY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow BWAY usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How BWAY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for BWAYHow many large options trades hit BWAY, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

BWAY Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●29 buying vs 27 selling
  • ●Shares held by funds -0.7%
  • ▲Funds holding +9
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding6556+16.1%
In funds' top 10110.0%
Held by funds–––
New / increased18 / 118 / 15+26.1%
Reduced / sold out18 / 919 / 80.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BWAY institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BWAY is in one of them and how their past BWAY trades turned out.

BWAY in the AI portfolios
Loading…

BWAY News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BWAY in an article yet. Here's the latest on the wider market.

BWAY in the news

About Brainsway

BrainsWay is a medical technology company based in Jerusalem, Israel. It makes Deep TMS systems, which use magnetic pulses to stimulate brain regions in a noninvasive way to treat mental health conditions. The treatments are cleared in the United States for depression, including anxious depression, and obsessive-compulsive disorder, and the company markets them for smoking addiction. It sells its systems to psychiatrists' offices and other treatment facilities that care for these patients.

Headquarters
Jerusalem, Israel
Founded
2003